Acetylsalicylic acid Completed Phase 4 Trials for Coronary Artery Disease / Aspirin Resistance Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01159639Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting